HuGE Literature Finder
Records
1
-
8
The Relationship of ABCB1/MDR1 and CYP1A1 Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma. Journal of clinical medicine 2021 11 10 (22): . Zmorzynski Szymon, Wojcierowska-Litwin Magdalena, Popek-Marciniec Sylwia, Szudy-Szczyrek Aneta, Styk Wojciech, Chocholska Sylwia, Filip Agata An |
Influence of ABCB1 polymorphisms on the pharmacokinetics and toxicity of lenalidomide in patients with multiple myeloma. Medical oncology (Northwood, London, England) 2019 5 36 (6): 55. Kobayashi Takahiro, Miura Masatomo, Abumiya Maiko, Akamine Yumiko, Ito Fumiko, Takahashi Nao |
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients. British journal of haematology 2018 Aug . Macauda Angelica, Castelli Eleonora, Buda Gabriele, Pelosini Matteo, Butrym Aleksandra, Watek Marzena, Kruszewski Marcin, Vangsted Annette Juul, Rymko Marcin, Jamroziak Krzysztof, Abildgaard Niels, Haastrup Eva Kannik, Mazur Grzegorz, Ríos Rafael, Jurczyszyn Artur, Zawirska Daria, Dudzi?ski Marek, Ra?ny Ma?gorzata, Dutka Magdalena, Tomczak Waldemar, Suska Anna, Druzd-Sitek Agnieszka, Marques Herlander, Petrini Mario, Markiewicz Miroslaw, Martinez-Lopez Joaquin, Ebbesen Lene Hyldahl, Iskierka-Ja?d?ewska El?bieta, Sainz Juan, Canzian Federico, Campa Danie |
Multidrug resistance 1 (MDR1/ABCB1) gene polymorphism (rs1045642 C?>?T) and susceptibility to multiple myeloma: a systematic review and meta-analysis. Hematology (Amsterdam, Netherlands) 2018 Mar 1-7. Razi Bahman, Anani Sarab Gholamreza, Omidkhoda Azadeh, Alizadeh Shah |
Association of ABCB1 T-129C polymorphism and multiple myeloma risk in Polish population. Polish journal of pathology : official journal of the Polish Society of Pathologists 2018 69 (4): 405-409. Niebudek Katarzyna, Balcerczak Ewa, Mirowski Marek, Zebrowska Mar |
Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial. Cancer chemotherapy and pharmacology 2018 01 81 (1): 183-193. Jakobsen Falk Ingrid, Lund Johan, Gréen Henrik, Gruber Astrid, Alici Evren, Lauri Birgitta, Blimark Cecilie, Mellqvist Ulf-Henrik, Swedin Agneta, Forsberg Karin, Carlsson Conny, Hardling Mats, Ahlberg Lucia, Lotfi Kourosh, Nahi Hare |
Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium. Leukemia 2012 Jun 26 (6): 1419-22. Martino A, Campa D, Buda G, Sainz J, García-Sanz R, Jamroziak K, Reis R M, Weinhold N, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Szemraj J, Stein A, Kumar R, Orciuolo E, Gemignani F, Landi S, Goldschmidt H, Petrini M, Dumontet C, Canzian F, Rossi A |
Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma. Leukemia research 2009 Feb 33 (2): 332-5. Jamroziak Krzysztof, Balcerczak Ewa, Calka Karolina, Piaskowski Sylwester, Urbanska-Rys Halina, Salagacka Aleksandra, Mirowski Marek, Robak Tadeu |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 29, 2023
- Content source: